Free List Of Top 10 Biosimilars Distribution Companies

With the growing demand for biosimilars in the United States, distribution companies play a crucial role in ensuring that these important pharmaceutical products reach the market effectively. Biosimilars are biologic products that are highly similar to, and have no clinically meaningful differences from, an existing FDA-approved reference product. They offer cost-effective alternatives to expensive biologic drugs, expanding patient access to essential treatments. In this article, we will provide an overview of the top 10 biosimilars distribution companies in the US, including details such as their sector, year founded, annual revenue, short description, and a link to their website.

Company 1: AmerisourceBergen Corporation

– Sector: Healthcare

– Year Founded: 2001

– Annual Revenue: $187.7 billion (2020)

– Description: AmerisourceBergen Corporation is a global healthcare solutions leader. They are committed to delivering innovative products and services that drive quality and efficiency in pharmaceutical care. AmerisourceBergen plays an integral role in providing biosimilars to healthcare providers and patients across the United States.

– [Visit AmerisourceBergen Corporation](https://www.amerisourcebergen.com)

Company 2: McKesson Corporation

– Sector: Healthcare

– Year Founded: 1833

– Annual Revenue: $238.1 billion (2020)

– Description: As one of the largest healthcare companies in the world, McKesson Corporation distributes pharmaceuticals, medical supplies, and health information technology. Their robust network ensures the efficient distribution of biosimilars, contributing to improved access to these vital medications.

– [Visit McKesson Corporation](https://www.mckesson.com)

Company 3: Cardinal Health, Inc

– Sector: Healthcare

– Year Founded: 1979

– Annual Revenue: $152.9 billion (2020)

– Description: Cardinal Health, Inc. is a global, integrated healthcare services and products company. They work collaboratively with pharmaceutical manufacturers to bring biosimilars to market and deliver them to healthcare facilities, pharmacies, and patients across the US.

– [Visit Cardinal Health, Inc](https://www.cardinalhealth.com)

Company 4: Amerigen Pharmaceuticals Limited

– Sector: Pharmaceuticals

– Year Founded: 2012

– Annual Revenue: Not publicly disclosed

– Description: Amerigen Pharmaceuticals Limited is a specialty generic pharmaceutical company focused on the development, manufacture, and sale of biosimilar products. They partner with leading distribution channels to ensure their biosimilars reach patients in need.

– [Visit Amerigen Pharmaceuticals Limited](https://www.amerigenpharma.com)

Company 5: Apotex Inc

– Sector: Pharmaceuticals

– Year Founded: 1974

– Annual Revenue: Not publicly disclosed

– Description: Apotex Inc. is a Canadian pharmaceutical corporation that manufactures and distributes high-quality generic and biosimilar medications. Their presence in the US market contributes to the availability and affordability of biosimilars for patients and healthcare providers.

– [Visit Apotex Inc](https://www.apotex.com)

Company 6: Sandoz, a Novartis Division

– Sector: Pharmaceuticals

– Year Founded: 1946

– Annual Revenue: Not publicly disclosed

– Description: Sandoz is a global leader in generic and biosimilar pharmaceuticals. Their extensive portfolio and distribution network in the US play a significant role in making biosimilars accessible to patients, addressing unmet medical needs.

– [Visit Sandoz, a Novartis Division](https://www.sandoz.com)

Company 7: Teva Pharmaceutical Industries Ltd

– Sector: Pharmaceuticals

– Year Founded: 1901

– Annual Revenue: $16.7 billion (2019)

– Description: Teva Pharmaceutical Industries Ltd is a multinational pharmaceutical company with a focus on generic and specialty medicines. They are actively involved in the distribution of biosimilars, enabling greater availability and affordability for patients in the US.

– [Visit Teva Pharmaceutical Industries Ltd](https://www.tevapharm.com)

Company 8: Pfizer Inc

– Sector: Pharmaceuticals

– Year Founded: 1849

– Annual Revenue: $51.8 billion (2020)

– Description: Pfizer Inc. is a leading biopharmaceutical company that develops and distributes innovative and biosimilar medicines. Their commitment to advancing healthcare includes ensuring the successful distribution of biosimilars to meet patient needs.

– [Visit Pfizer Inc](https://www.pfizer.com)

Company 9: Mylan N.V

– Sector: Pharmaceuticals

– Year Founded: 1961

– Annual Revenue: Not publicly disclosed

– Description: Mylan N.V. is a global pharmaceutical company that focuses on making high-quality medicines accessible to people around the world. Their distribution channels play a vital role in delivering biosimilars to patients and healthcare systems in the US.

– [Visit Mylan N.V](https://www.mylan.com)

Company 10: Celltrion Inc

– Sector: Biotechnology

– Year Founded: 2002

– Annual Revenue: Not publicly disclosed

– Description: Celltrion Inc. is a leading South Korean biopharmaceutical company specializing in the development and distribution of biosimilars. Their presence in the US market helps expand the availability of these critical medications to healthcare providers and patients.

– [Visit Celltrion Inc](https://www.celltrion.com)

The distribution of biosimilars in the US is facilitated by these top companies, each playing a crucial role in ensuring that these important pharmaceutical products are accessible to healthcare providers and patients. Their efforts contribute to expanding treatment options and improving patient outcomes across the country.